| Syphilis |
1 |
1 |
| Chlamydial Infection |
0 |
0.99 |
| Clinical Guidelines |
0 |
0.46 |
| Gonorrhea |
0 |
0.98 |
| Antibiotics |
0 |
0.4 |
| Social Determinants of Health |
0 |
0.96 |
| Clinical Research |
0 |
0.27 |
| Sexually Transmitted Infection |
0 |
0.97 |
| Healthcare and Medical Technology |
0 |
0.24 |
| Patient Safety |
0 |
0.21 |
| Adherence |
0 |
0.18 |
| Adverse Effects |
0 |
0.18 |
| Transgender |
0 |
0.18 |
| HIV Infection |
0 |
0.16 |
| AIDS |
0 |
0.09 |
| Allergy |
0 |
0.09 |
| Antibiotic Resistance |
0 |
0.09 |
| Diversity |
0 |
0.09 |
| Epidemic |
0 |
0.09 |
| Opportunistic Infection |
0 |
0.09 |
| Prophylaxis |
0 |
0.09 |
| Stigma |
0 |
0.09 |
| Washington |
0 |
0.09 |